DE69521328T2 - Kaffein-formulierung mit verzögerter freisetzung - Google Patents

Kaffein-formulierung mit verzögerter freisetzung

Info

Publication number
DE69521328T2
DE69521328T2 DE69521328T DE69521328T DE69521328T2 DE 69521328 T2 DE69521328 T2 DE 69521328T2 DE 69521328 T DE69521328 T DE 69521328T DE 69521328 T DE69521328 T DE 69521328T DE 69521328 T2 DE69521328 T2 DE 69521328T2
Authority
DE
Germany
Prior art keywords
delayed release
caffeine formulation
caffeine
formulation
delayed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69521328T
Other languages
English (en)
Other versions
DE69521328D1 (de
Inventor
Francoise Chauffard
Marc Y A Enslen
Pierre Tachon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe des Produits Nestle SA
Nestle SA
Original Assignee
Societe des Produits Nestle SA
Nestle SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe des Produits Nestle SA, Nestle SA filed Critical Societe des Produits Nestle SA
Publication of DE69521328D1 publication Critical patent/DE69521328D1/de
Application granted granted Critical
Publication of DE69521328T2 publication Critical patent/DE69521328T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
DE69521328T 1994-12-16 1995-11-27 Kaffein-formulierung mit verzögerter freisetzung Expired - Lifetime DE69521328T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/357,689 US5744164A (en) 1994-12-16 1994-12-16 Sustained release microparticulate caffeine formulation
PCT/IB1995/001056 WO1996018389A1 (en) 1994-12-16 1995-11-27 Sustained release caffeine formulation

Publications (2)

Publication Number Publication Date
DE69521328D1 DE69521328D1 (de) 2001-07-19
DE69521328T2 true DE69521328T2 (de) 2002-01-17

Family

ID=23406640

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69521328T Expired - Lifetime DE69521328T2 (de) 1994-12-16 1995-11-27 Kaffein-formulierung mit verzögerter freisetzung

Country Status (21)

Country Link
US (2) US5744164A (de)
EP (2) EP0716853A1 (de)
JP (1) JPH10510529A (de)
AR (1) AR002947A1 (de)
AT (1) ATE201986T1 (de)
AU (1) AU694810B2 (de)
CA (1) CA2208149C (de)
CO (1) CO4600671A1 (de)
DE (1) DE69521328T2 (de)
DK (1) DK0789562T3 (de)
ES (1) ES2158956T3 (de)
GR (1) GR3036501T3 (de)
HK (1) HK1000878A1 (de)
IL (1) IL116066A (de)
NZ (1) NZ295245A (de)
PE (1) PE55396A1 (de)
PT (1) PT789562E (de)
RU (1) RU2144353C1 (de)
TR (1) TR199501560A2 (de)
WO (1) WO1996018389A1 (de)
ZA (1) ZA9510687B (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6122496A (en) * 1995-06-20 1997-01-22 Pharma-Vinci A/S A method of preparing an oral preparation provided on the outer side with an enteric coating, as well as an oral preparation obtained by the method
US6531114B1 (en) 1999-04-06 2003-03-11 Wm. Wrigley Jr. Company Sildenafil citrate chewing gum formulations and methods of using the same
US6627234B1 (en) 1998-12-15 2003-09-30 Wm. Wrigley Jr. Company Method of producing active agent coated chewing gum products
US7163705B2 (en) * 1998-12-15 2007-01-16 Wm. Wrigley Jr. Company Coated chewing gum product and method of making
US6586023B1 (en) 1998-12-15 2003-07-01 Wm. Wrigley Jr. Company Process for controlling release of active agents from a chewing gum coating and product thereof
US6322806B1 (en) 1999-04-06 2001-11-27 Wm. Wrigley Jr. Company Over-coated chewing gum formulations including tableted center
US6773716B2 (en) 1999-04-06 2004-08-10 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US6426090B1 (en) * 1999-04-06 2002-07-30 Wm. Wrigley Jr. Company Over-coated product including tableted center and medicament
US7935362B2 (en) * 1999-04-06 2011-05-03 Wm. Wrigley Jr. Company Over-coated product including consumable center and medicament
US20020159956A1 (en) * 1999-04-06 2002-10-31 Ream Ronald L. Over-coated chewing gum formulations
US6355265B1 (en) 1999-04-06 2002-03-12 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US6663849B1 (en) 2000-09-01 2003-12-16 Wm. Wrigley Jr. Company Antacid chewing gum products coated with high viscosity materials
US6541048B2 (en) 1999-09-02 2003-04-01 Wm. Wrigley Jr. Company Coated chewing gum products containing an acid blocker and process of preparing
US6569472B1 (en) 2000-09-01 2003-05-27 Wm. Wrigley Jr. Company Coated chewing gum products containing antacid and method of making
US6645535B2 (en) 1999-09-02 2003-11-11 Wm. Wrigley Jr. Company Method of making coated chewing gum products containing various antacids
AU3885201A (en) * 1999-09-20 2001-04-24 Mastercare Diet and weight control gum and sucker
US9387168B2 (en) 1999-09-20 2016-07-12 Jack Barreca Chewing gum with tomatidine
US9253991B2 (en) 1999-09-20 2016-02-09 Jack Barreca Chewing gum with B vitamins
US8178150B2 (en) 2000-02-22 2012-05-15 Suzanne Jaffe Stillman Water containing soluble fiber
US7892586B2 (en) 2001-02-22 2011-02-22 Suzanne Jaffe Stillman Water containing soluble fiber
US7115297B2 (en) 2000-02-22 2006-10-03 Suzanne Jaffe Stillman Nutritionally fortified liquid composition with added value delivery systems/elements/additives
US7115288B2 (en) * 2000-06-09 2006-10-03 Wm. Wrigley Jr. Company Method for making coated chewing gum products with a coating including an aldehyde flavor and a dipeptide sweetener
US6572900B1 (en) 2000-06-09 2003-06-03 Wm. Wrigley, Jr. Company Method for making coated chewing gum products including a high-intensity sweetener
US6444241B1 (en) 2000-08-30 2002-09-03 Wm. Wrigley Jr. Company Caffeine coated chewing gum product and process of making
US6579545B2 (en) 2000-12-22 2003-06-17 Wm. Wrigley Jr. Company Coated chewing gum products containing an antigas agent
US7897141B2 (en) * 2002-04-01 2011-03-01 Drexel University Echogenic polymer microcapsules and nanocapsules and methods for production and use thereof
US20030220351A1 (en) * 2002-05-24 2003-11-27 Gilbert Gonzales Enteric coated caffeine tablet
EP1565062A1 (de) * 2002-11-25 2005-08-24 Phares Pharmaceutical Research N.V. Süsswaren-zusammensetzung
US20050181044A1 (en) * 2004-02-18 2005-08-18 Jaime Romero Compositions and methods for timed release of water-soluble nutritional supplements, green coffee extract
US20050220875A1 (en) * 2004-03-31 2005-10-06 Agency For Science, Technology And Research Sustained-release tablet formulation
FR2883179B1 (fr) 2005-03-18 2009-04-17 Ethypharm Sa Comprime enrobe
US8486452B2 (en) 2007-07-20 2013-07-16 Mylan Pharmaceuticals Inc. Stabilized tolterodine tartrate formulations
US8110226B2 (en) * 2007-07-20 2012-02-07 Mylan Pharmaceuticals Inc. Drug formulations having inert sealed cores
US7985727B1 (en) 2007-09-20 2011-07-26 Abbott Cardiovascular Systems Inc. Apo A-I mimetic peptides and methods of treatment
US9173890B2 (en) * 2007-09-20 2015-11-03 Abbott Cardiovascular Systems Inc. Sustained release of Apo A-I mimetic peptides and methods of treatment
US8101565B2 (en) * 2007-09-20 2012-01-24 Abbott Cardiovascular Systems Inc. Sustained release of Apo A-I mimetic peptides and methods of treatment
US8044021B2 (en) * 2007-09-20 2011-10-25 Abbott Cardiovascular Systems Inc. Sustained release of apo A-I mimetic peptides and methods of treatment
US7985728B1 (en) 2007-09-20 2011-07-26 Abbott Cardiovascular Systems Inc. Sustained release of Apo A-I mimetic peptides and methods of treatment
MX2011007819A (es) * 2009-01-22 2011-12-16 Abbott Healthcare Private Ltd Composicion farmaceutica cronoterapeutica.
US8545892B2 (en) 2009-06-26 2013-10-01 Nano Pharmaceutical Laboratories, Llc Sustained release beads and suspensions including the same for sustained delivery of active ingredients
US8992898B2 (en) 2010-04-17 2015-03-31 Shannon Elizabeth Klingman Antiperspirants and deodorants
WO2014197601A1 (en) * 2013-06-04 2014-12-11 KVK-Tech, Inc. Controlled release caffeine dosage forms
BR112017014953A2 (pt) 2015-01-12 2018-03-13 Nano Pharmaceutical Laboratories Llc microglóbulos de liberação controlada em camadas e métodos para produção dos mesmos
KR101644154B1 (ko) * 2015-09-08 2016-07-29 주식회사 스킨앤테크 수용성 카페인 및 그 제조방법
US10582716B1 (en) 2019-06-14 2020-03-10 Lennham Pharmaceuticals, Inc. Deuterated caffeine and uses thereof
US20220288083A1 (en) * 2021-03-09 2022-09-15 Lennham Pharmaceuticals, Inc. D9-caffeine compositions and uses thereof
WO2023004733A1 (zh) * 2021-07-30 2023-02-02 宝龄富锦生技股份有限公司 控制释放口服制剂及其制备方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1249219B (de) * 1958-12-22 1967-09-07 The National Cash Register Company, Dayton, Ohio (V. St. A.) Herstellen von Mikrokapseln, die eine Emulsion aus Öl in hydrophiler Flüssigkeit enthalten
US3265629A (en) * 1958-12-22 1966-08-09 Ncr Co Coating by phase separation
DE2010416B2 (de) * 1970-03-05 1979-03-29 Hoechst Ag, 6000 Frankfurt Oral anwendbare Arzneiform mit Retardwirkung
US4001480A (en) * 1974-08-16 1977-01-04 Swift & Company Encapsulation process utilizing microorganisms and products produced thereby
IE55745B1 (en) * 1983-04-06 1991-01-02 Elan Corp Plc Sustained absorption pharmaceutical composition
EP0185127B1 (de) * 1983-06-24 1988-09-21 Dridrinks N.V. Verfahren zum Behandeln von Säuren als Komponenten für pulverförmige, wasserlösliche Zusammensetzungen für Getränke mit andauernder Gasabgabe.
NZ207813A (en) * 1983-06-24 1986-12-05 Dridrinks Nv Effervescent mixture:component(s)coated with water-soluble polysaccharide composition
NZ210785A (en) * 1984-01-13 1987-11-27 Battelle Development Corp Liquid dispersions of layered controlled release dosage forms
DE3403329A1 (de) * 1984-02-01 1985-08-01 Horst Dr. 4019 Monheim Zerbe Pharmazeutisches produkt in form von pellets mit kontinuierlicher, verzoegerter wirkstoffabgabe
AU571312B2 (en) * 1984-02-10 1988-04-14 Nycomed Danmark A/S Diffusion coated multiple-units dosage form
DK62184D0 (da) * 1984-02-10 1984-02-10 Benzon As Alfred Diffusionsovertrukket polydepotpraeparat
NL8500724A (nl) * 1985-03-13 1986-10-01 Univ Groningen Inrichtingen voor geregelde afgifte van werkzame stoffen, alsmede werkwijze ter vervaardiging daarvan.
DE3537770A1 (de) * 1985-10-24 1987-04-30 Basf Ag Salze mehrwertiger kationen von polymerisaten von konjugierten dienen
US4853249A (en) * 1985-11-15 1989-08-01 Taisho Pharmaceutical Co., Ltd. Method of preparing sustained-release pharmaceutical/preparation
JP2541835B2 (ja) * 1986-04-07 1996-10-09 ローヌ―プーラン ローラー インターナショナル（ホウルディングス） インコーポレイテッド 持続放出型薬理組成物の製法およびこれにより得られる組成物
US5026709A (en) * 1986-04-07 1991-06-25 Rorer Pharmaceutical Corporation Method for the preparation of a theophylline sustained release pharmaceutical composition and the composition prepared thereby
GB8613689D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
US5200193A (en) * 1987-04-22 1993-04-06 Mcneilab, Inc. Pharmaceutical sustained release matrix and process
JP2643222B2 (ja) * 1988-02-03 1997-08-20 エーザイ株式会社 多重層顆粒
US4971785A (en) * 1988-03-14 1990-11-20 Spectrum Consumer Products Co., Inc. Non-alcoholic delivery system for orally ingestible active ingredients
CA2007181C (en) * 1989-01-06 1998-11-24 Angelo Mario Morella Sustained release pharmaceutical composition
US5202128A (en) * 1989-01-06 1993-04-13 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
US5330766A (en) * 1989-01-06 1994-07-19 F. H. Faulding & Co. Limited Sustained release pharmaceutical composition
JPH06316517A (ja) * 1993-02-22 1994-11-15 Grelan Pharmaceut Co Ltd 放出制御製剤

Also Published As

Publication number Publication date
TR199501560A2 (tr) 1996-07-21
CO4600671A1 (es) 1998-05-08
HK1000878A1 (en) 2001-10-26
DE69521328D1 (de) 2001-07-19
AU3854295A (en) 1996-07-03
US5700484A (en) 1997-12-23
IL116066A0 (en) 1996-01-31
NZ295245A (en) 1999-01-28
CA2208149A1 (en) 1996-06-20
IL116066A (en) 2000-10-31
RU2144353C1 (ru) 2000-01-20
GR3036501T3 (en) 2001-11-30
PT789562E (pt) 2001-10-30
ATE201986T1 (de) 2001-06-15
EP0789562A1 (de) 1997-08-20
JPH10510529A (ja) 1998-10-13
US5744164A (en) 1998-04-28
CA2208149C (en) 2007-03-27
PE55396A1 (es) 1996-12-24
EP0716853A1 (de) 1996-06-19
AR002947A1 (es) 1998-05-27
ZA9510687B (en) 1996-07-03
WO1996018389A1 (en) 1996-06-20
AU694810B2 (en) 1998-07-30
DK0789562T3 (da) 2001-09-03
ES2158956T3 (es) 2001-09-16
EP0789562B1 (de) 2001-06-13

Similar Documents

Publication Publication Date Title
DE69521328T2 (de) Kaffein-formulierung mit verzögerter freisetzung
DK1468679T3 (da) Tramadolholdig formulering med styret frigivelse
FI943168A (fi) Opioidiformulaatioita, joissa on pitkitetty säädelty vapautuminen
DE69506086T2 (de) Zusammensetzung mit gesteuerter freisetzung
BR9701304A (pt) Formulação de liberação prolongada
DE69401971D1 (de) Magnetothermische Auslöseeinheit
DE69739957D1 (de) Absorbierender Gegenstand
DE69721343D1 (de) FPGA mit Setz-/Rücksetzleitungen
DE69709946D1 (de) Absorbierender artikel
DE69628860D1 (de) Absorbierende artikel mit trennmittel
DE59707743D1 (de) Absorbierender artikel
NO20002126D0 (no) Formulering med forlenget frigjøring
NO20001375D0 (no) Legemiddelformulering med kontrollert virkestoffrigivning
DE69524611D1 (de) Pyrimidon-derivate
ATE237927T1 (de) Pestizidformulierung mit langsamer freisetzung
DE69717773T2 (de) Pestizidformulierung mit kontrollierter Freisetzung
FI954348A (fi) Säädetysti vapauttava alumiinia sisältävä farmaseuttinen valmiste
NO993024L (no) Polysakkarid-peptid-derivater
MX9200120A (es) Compuestos de bipiridilo y procedimiento para su preparacion
DE9408070U1 (de) Lösespitze
DE29711869U1 (de) Sperrdübel
NO971030L (no) Preparat med langvarig frigjöring
KR970049093U (ko) 바이오메트리스카바

Legal Events

Date Code Title Description
8364 No opposition during term of opposition